Company Overview and News

CIMB first bank in Malaysia to introduce QR acceptance on payment terminals

2018-10-02 theedgemarkets
KUALA LUMPUR (Oct 2): CIMB Bank Bhd has teamed up with payment system company GHL Systems Bhd to become the first bank in Malaysia to introduce quick response (QR) payment acceptance at its terminals, accepting payments through six major mobile wallets on one terminal.

GHL Systems downgraded to reduce at CIMB

2018-08-24 theedgemarkets
KUALA LUMPUR (Aug 24): CIMB analyst Mohd Shanaz Noor Azam downgraded the recommendation on GHL Systems Bhd to reduce from add.

Creador commits RM1bil in Malaysia

His private equity (PE) firm Creador Sdn Bhd recently closed its fourth fund at over US$500mil (RM2bil), making it one of the largest capital raised for a Malaysian-based PE firm.
SOMANYCERA 531548 0021

Tech: Consolidation seen further ahead in the crowded e-wallet space

2018-07-25 theedgemarkets
Ong: ... we will continue to bring mobile applications that are as frictionless as possible through the banks
1155 5139 1023 MLYBY 0900 MLYNF 0082 0021 CIMDF

GHL Systems consolidating, says AllianceDBS Research

2018-07-17 theedgemarkets
KUALA LUMPUR (July 18): AllianceDBS Research said GHL Systems Bhd (Ghlsys) had on July 17 tested previous day’s high of RM1.64 before closing at RM1.63 (up 1 sen or 0.61%).

Trading ideas: DBE Gurney, Salcon, GHL Systems, Nova MSC

KUALA LUMPUR: JF Apex Research expects DBE Gurney Resources Bhd , Salcon Bhd , GHL Systems Bhd and Nova MSC Bhd to be among the stocks to watch on Tuesday.
0026 0021

DBE Gurney, KLCC Stapled Group, Salcon, TFP Solutions, Pasdec, GHL Systems, Nova MSC and Xinghe

2018-07-16 theedgemarkets
KUALA LUMPUR (July 16): Based on corporate announcements and news flow today, companies that may be in focus on Tuesday (July 17) may include the following: DBE Gurney Resources Bhd, KLCC Stapled Group, Salcon Bhd, TFP Solutions Bhd, Pasdec Holdings Bhd, GHL Systems Bhd, Nova MSC Bhd and Xinghe Holdings Bhd.
6912 0145 0026 BSMAF 0095 0021 1818

GHL Systems appointed as direct merchant acquirer for UnionPay in Malaysia

2018-07-16 theedgemarkets
KUALA LUMPUR (July 16): GHL Systems Bhd has been appointed as a direct merchant acquirer for UnionPay International in Malaysia.

Nova MSC confident of returning to the black in FY19

2018-07-11 theedgemarkets
Nova MSC Bhd (July 10, 18 sen) Not rated: Nova MSC Bhd is an ACE Market-listed company primarily involved in developing and supplying smart e-solutions in three main segments: smart healthcare, government digitalisation, and building automation and control. It targets both government and private entities. All its softwares are developed fully in-house. Nova’s current operations are mainly in Singapore (98% of its financial year 2018 [FY18] revenue) but it also has presence in other Southeast Asian countries such as Brunei, Malaysia, and Indonesia.
5216 4456 0026 0021

Stock With Momentum: GHL Systems

2018-07-02 theedgemarkets
GHL Systems Bhd (-ve) Shares in payment service provider GHL Systems Bhd (fundamental: 2.2/3, valuation: 0.2/3), which triggered our momentum algorithm last Friday for the first time this year, closed five sen or 3.15% higher at RM1.64.

GHL Systems

2018-06-29 theedgemarkets
KUALA LUMPUR (June 29): highlighted one stock with negative momentum at Bursa Malaysia’s afternoon market close today.
BSMAF 0021 1818

Riding the Asean e-payment wave with GHL Systems

2018-06-26 theedgemarkets
IN slightly over a year, GHL Systems has managed to rope in two foreign strategic investors. And they were willing to pay a price that values GHL at a price-earnings ratio of above 30 times.

Trading ideas: Kimlun, Gabungan AQRS, GHL, Scientex, MyNews, MyEG, DNeX

KUALA LUMPUR: Kimlun Corp, Gabungan AQRS, GHL Systems Bhd and Scientex Bhd are among the stocks to watch on Thursday, according to JF Apex Research.
5226 4456 0021

Tech stocks continue to rise

Uptrend: A Unisem facility in China. Semiconductor manufacturers such as Malaysian Pacific Industries Bhd, Unisem (M) Bhd and Pentamaster Corp Bhd have been on a steady rise following a sell-down in the counters
0166 3867 BSMAF 0021 1818

KLCI to trade range bound, take cue from global markets

2018-06-20 theedgemarkets
KUALA LUMPUR (June 21): The FBM KLCI is expected to trade range bound today, taking cue from the overnight close at most global markets.
5226 4456 7251 4405 3034 0021

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...